The Why? For IE Executive Business

Education.Anthony Kamau Njuguna.

More than 1 billion people have no access to essential drugs worldwide.

Essential medicines-those that meet a community or nations health needs are cost-effective, save lives and improve quality of life.

Poor drug selection, costly procurement, stock-outs in health facilities, inadequate storage facilities, lack of adequate health personnel, lack of requisite skills in health supply chain are some challenges facing Africa.

This sad state affairs has left many dead before the age of 5 years in Africa, and many other adults dying of preventable and treatable conditions.

The public health system that is used by majority of people is ill-equipped to handle the disease burden, mainly due to underfunding of health services.

Part of the dilemma can be solved by ensuring advocacy for adequate funding from governments, donors and relevant stakeholders and to train health workers to use the available resources in the most cost effective manner.

With the advent of innovative financing mechanisms for healthcare, like the Global Funds to fight HIV,TB and Malaria, the need to get build supply chain capacity in Africa is becoming evident in order to best make use of resources available through such Funds to improve the health of Africa and ensure that the remote areas are reached with these lifesaving drugs.

An MBA from IE Business School will equip me with the requisite leadership and business skills to advocate for increased Funding depending on context, through various Funding agents, build the skills to manage available human and other resource at a government or international health agency to improve healthcare in Africa. More specifically through the innovative thinking that I will learn, to increase therapeutic efficacy (how well drugs are used to create health benefits for populations from current 30% towards 70% percent in Africa).

Africa Arise!